Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
Summary
Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
Detailed description
The PRIME study aims to improve colorectal cancer (CRC) screening and follow-up among predominantly Latinx populations by using video text messages, mailed FIT kits, and patient navigation. The study will address multi-level barriers to screening, including misinformation, lack of access, and social determinants of health. The hypothesis is that a multi-component intervention will increase CRC screening rates and follow-up care, reducing disparities in CRC outcomes.
Arms & interventions
- BehavioralVideo text message
Video text messages tailored to the Latinx population to educate and motivate patients to complete CRC screening.
- BehavioralIn-clinic CRC screening promotion
Stool-test orders, colonoscopy referrals.
- BehavioralMailed FIT
Mailed FIT kits.
- BehavioralSocial needs navigation
Patient navigation to address social needs.
- BehavioralReminders
Centralized text and/or telephone reminders for ordered tests.
Outcome measures
Primary
CRC Screening Completion at the Individual Level
Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.
Time frame: 6 months
Secondary
FIT completion
Time frame: 6 months
Rate of Follow-Up Colonoscopy Completion
Time frame: 12 months
Time to follow-up colonoscopy
Time frame: Within 12 months post abnormal FIT result
Eligibility criteria
Study locations (1)
AltaMed Health Services Corporation
Los Angeles, California, 90040
References
- Rivelli JS, Schneider JL, Vaughn KA, Locher BW, Shaw MC, Martinez LS, Ruiz E, Thompson JH, Escaron AL, Coronado GD. Improving animated instructional videos for colorectal cancer screening: An application of learner verification and revision. Transl Behav Med. 2025 Jan 16;15(1):ibaf020. doi: 10.1093/tbm/ibaf020.(PubMed)